CD4 and neoplasm: Tumor-infiltrating NK cells are associated with Tregs, and an increase in CD4+ CD25+ Tregs may impair the ability of tumor-infiltrating NK cells to produce IFN-γ and eliminate K562 targets, thereby affecting their anti-tumor efficacy (Figure 2) (93).